High throughput assay for the determination of lumefantrine in plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 822, Issue 1-2, 2005, Pages 330-333

  Annerberg, A ^a   Singtoroj, T ^a   Tipmanee, P ^a   White, N J ^a,b   Day, N P J ^a,b   Lindegardh N ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

96 Well; Antimalarial; High throughput; Liquid chromatography; Lumefantrine; Solid phase extraction

Indexed keywords

BIOASSAY; BIOMEDICAL ENGINEERING; CHEMICAL ANALYSIS; CHROMATOGRAPHIC ANALYSIS; CONCENTRATION (PROCESS); DRUG THERAPY;

BIOANALYTICAL ASSAY; LIMITS OF DETECTION (LOD); LUMEFANTRINE; THERAPEUTIC DRUGS;

PLASMA DEVICES;

BENFLUMETOL;

ACCURACY; ARTICLE; BLOOD SAMPLING; CHROMATOGRAPHY; CONCENTRATION (PARAMETERS); DRUG DETERMINATION; DRUG MONITORING; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; SAMPLE; VALIDATION PROCESS;

ANTIMALARIALS; CHROMATOGRAPHY, LIQUID; ETHANOLAMINES; FLUORENES; HUMANS; REPRODUCIBILITY OF RESULTS;

EID: 22244445801     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2005.06.022     Document Type: Article

References (15)

1. L. von Seidlein, S. Jaffar, M. Pinder, M. Haywood, G. Snounou, B. Gemperli, I. Gathmann, C. Royce, and B. Greenwood J. Infect. Dis. 176 1997 1113
2. C. Hatz, S. Abdulla, R. Mull, D. Schellenberg, I. Gathmann, P. Kibatala, H.P. Beck, M. Tanner, and C. Royce Trop. Med. Int. Health 3 1998 498
3. M. van Vugt, A. Brockman, B. Gemperli, C. Luxemburger, I. Gathmann, C. Royce, T. Slight, S. Looareesuwan, N.J. White, and F. Nosten Antimicrob. Agents Chemother. 42 1998 135
4. M. van Vugt, S. Looareesuwan, P. Wilairatana, R. McGready, L. Villegas, I. Gathmann, R. Mull, A. Brockman, N.J. White, and F. Nosten Trans. R. Soc. Trop. Med. Hyg. 94 2000 545
5. C. Falade, M. Makanga, Z. Premji, C.E. Ortmann, M. Stockmeyer, and P.I. de Palacios Trans. R. Soc. Trop. Med. Hyg. 99 2005 459
6. D. Colussi, C. Parisot, F. Legay, and G. Lefevre Eur. J. Pharm. Sci. 9 1999 9
7. F. Ezzet, M. van Vugt, F. Nosten, S. Looareesuwan, and N.J. White Antimicrob. Agents Chemother. 44 2000 697
8. S.M. Mansor, V. Navaratnam, N. Yahaya, N.K. Nair, W.H. Wernsdorfer, and P.H. Degen J. Chromatogr. B 682 1996 321
9. M.Y. Zeng, Z.L. Lu, S.C. Yang, M. Zhang, J. Liao, S.L. Liu, and X.H. Teng J. Chromatogr. B 681 1996 299
10. N. Lindegardh, A. Annerberg, D. Blessborn, Y. Bergqvist, N. Day, and N.J. White J. Pharm. Biomed. Anal 37 2005 1081
11. Guidance for Industry Bioanalytical Method Validation, Department of Health and Human Services, Food and Drug Administration, Rockville, US, 2001.
12. Text on Validation of Analytical Procedures, Q2A (1994), ICH harmonised tripartite guideline.
13. Text on Validation of Analytical Procedures:Methodology, Q2B (1996), ICH harmonised tripartite guideline.
14. M. Mayxay, M. Khanthavong, N. Lindegardh, S. Keola, M. Barends, T. Pongvongsa, R. Yapom, A. Annerberg, S. Phompida, R. Phetsouvanh, N.J. White, and P.N. Newton Clin. Infect. Dis. 39 2004 1139
15. J.M. Stohrer, S. Dittrich, V. Thongpaseuth, V. Vanisaveth, R. Phetsouvanh, S. Phompida, F. Monti, E.M. Christophel, N. Lindegardh, A. Annerberg, and T. Jelinek Trop. Med. Int. Health 9 2004 1175